{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:02:21Z","timestamp":1792857741857,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12094-022-02808-9","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T14:02:52Z","timestamp":1650376972000},"page":"1605-1614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Adjuvant therapy in early-stage cervical cancer after radical hysterectomy: are we overtreating our patients? A meta-analysis"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5115-6668","authenticated-orcid":false,"given":"Natalia R.","family":"G\u00f3mez-Hidalgo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00darsula","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s G\u00f3mez","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Mico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Verges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente Bebia","family":"Conesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"P\u00e9rez-Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"P\u00e9rez-Benavente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gil-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"issue":"1","key":"2808_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"2808_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynecol Obstet. 2018;143:22\u201336.","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"2808_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.6004\/jnccn.2008.0005","volume":"6","author":"HJ Gray","year":"2008","unstructured":"Gray HJ. Primary management of early stage cervical cancer (IA1-IB) and appropriate selection of adjuvant therapy. J Natl Compr Canc Netw. 2008;6(1):47\u201352.","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"2808_CR4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","volume":"18","author":"WA Peters","year":"2000","unstructured":"Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606\u201313.","journal-title":"J Clin Oncol"},{"key":"2808_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/0090-8258(90)90072-S","volume":"38","author":"G Delgado","year":"1990","unstructured":"Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38:352\u20137.","journal-title":"Gynecol Oncol"},{"key":"2808_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/0002-9378(80)90285-9","volume":"138","author":"CK Chung","year":"1980","unstructured":"Chung CK, Nahhas WA, Stryker JA, Curry SL, Abt AB, et al. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol. 1980;138:550\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"2808_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/0090-8258(80)90068-2","volume":"10","author":"G Abdulhayoglu","year":"1980","unstructured":"Abdulhayoglu G, Rich WM, Reynolds J, DiSaia PJ. Selective radiation therapy in stage IB uterine cervical carcinoma following radical pelvic surgery. Gynecol Oncol. 1980;10:84\u201392.","journal-title":"Gynecol Oncol"},{"key":"2808_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/1097-0142(19840301)53:5<1175::AID-CNCR2820530524>3.0.CO;2-Y","volume":"53","author":"JG Boyce","year":"1984","unstructured":"Boyce JG, Fruchter RG, Nicastri AD, De Regt RH, et al. Vascular invasion in Stage I carcinoma of the cervix. Cancer. 1984;53:1175\u201380.","journal-title":"Cancer"},{"issue":"Suppl. 2","key":"2808_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/1097-0142(19810715)48:1+<560::AID-CNCR2820481320>3.0.CO;2-T","volume":"48","author":"M Rotman","year":"1981","unstructured":"Rotman M, John M, Boyce J. Prognostic factors in cervical carcinoma: implications in staging and management. Cancer. 1981;48(Suppl. 2):560\u20137.","journal-title":"Cancer"},{"key":"2808_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1006\/gyno.1999.5387","volume":"73","author":"A Sedlis","year":"1999","unstructured":"Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol. 1999;73:177\u201383.","journal-title":"Gynecol Oncol"},{"key":"2808_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","volume":"65","author":"M Rotman","year":"2006","unstructured":"Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, et al. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006;65:169\u201375.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"2808_CR12","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1245\/s10434-017-6031-z","volume":"24","author":"D Querleu","year":"2017","unstructured":"Querleu D, Cibula D, Abu-Rustum NR. 2017 Update on the Querleu-Morrow Classification of Radical Hysterectomy. Ann Surg Oncol. 2017;24(11):3406\u201312. https:\/\/doi.org\/10.1245\/s10434-017-6031-z.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2808_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ijgc-2019-000878","volume":"30","author":"D Cibula","year":"2020","unstructured":"Cibula D, Planchamp F, Fischerova D, Fotopoulou C, Kohler C, Landoni F, et al. European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer. Int J Gynecol Cancer. 2020;30(1):3\u201314. https:\/\/doi.org\/10.1136\/ijgc-2019-000878.","journal-title":"Int J Gynecol Cancer"},{"key":"2808_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007583.pub3","author":"L Rogers","year":"2012","unstructured":"Rogers L, Siu SSN, Luesley D, Bryant A, Dickinson HO. Radiotherapy and chemoradiation after surgery for early cervical cancer. Cochrane Database Syst Rev. 2012. https:\/\/doi.org\/10.1002\/14651858.CD007583.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"2808_CR15","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.","journal-title":"BMJ"},{"key":"2808_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"key":"2808_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/IGC.0000000000001216","volume":"28","author":"D Cibula","year":"2018","unstructured":"Cibula D, Potter R, Planchamp F, et al. The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer. Int J Gynecol Cancer. 2018;28:641\u201355. https:\/\/doi.org\/10.1097\/IGC.0000000000001216.","journal-title":"Int J Gynecol Cancer"},{"key":"2808_CR18","unstructured":"U.S Department of health and human services. Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 \u2013 November 27, 2017. Accesed online on November 2020 https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf"},{"key":"2808_CR19","first-page":"223","volume":"52","author":"K Bilek","year":"1982","unstructured":"Bilek K, Ebeling K, Leitsmann H, Seidel G. Radical pelvic surgery versus radical surgery plus radiotherapy for stage Ib carcinoma of the cervix uteri. Preliminary results of a prospective randomized clinical study. Arch Geschwulstforsch. 1982;52:223\u20139.","journal-title":"Arch Geschwulstforsch"},{"key":"2808_CR20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.47102\/annals-acadmedsg.V33N4p467","volume":"33","author":"MN Rushdan","year":"2004","unstructured":"Rushdan MN, Tay EH, Khoo-Tan HS, Lee KM, Low JH, et al. Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score- a pilot study. Ann Acad Med Singapore. 2004;33:367\u2013472.","journal-title":"Ann Acad Med Singapore"},{"key":"2808_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-016-0931-4","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Kitahara Y, Satoh T, Takei Y, Takano M, et al. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study). World J Surg Oncol. 2016. https:\/\/doi.org\/10.1186\/s12957-016-0931-4.","journal-title":"World J Surg Oncol"},{"key":"2808_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.10.018","author":"D Cibula","year":"2018","unstructured":"Cibula D, Abu-Rustum NR, Fischerova D, Pather S, Lavigne K, et al. Surgical treatment of \u201cintermediate risk\u201d lymph node negative cervical cancer patients without adjuvant radiotherapy\u2014a retrospective cohort study and review of the literature. Gynecol Oncol. 2018. https:\/\/doi.org\/10.1016\/j.ygyno.2018.10.018.","journal-title":"Gynecol Oncol"},{"key":"2808_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1006\/gyno.1997.4691","volume":"66","author":"JO Schoorge","year":"1997","unstructured":"Schoorge JO, Molpus KL, Koelliker D, Nikrui N, Goodman A, et al. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol. 1997;66:31\u20135.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2808_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0167-8140(99)00056-0","volume":"51","author":"A Snijders-Keilholz","year":"1999","unstructured":"Snijders-Keilholz A, Hellebrekers BW, Zwinderman A, van de Vijver M, Trimbos J. Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984\u20131996). Radiother Oncol. 1999;51(2):161\u20137.","journal-title":"Radiother Oncol"},{"key":"2808_CR25","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1136\/ijgc-00009577-200605000-00026","volume":"16","author":"QD Pieterse","year":"2006","unstructured":"Pieterse QD, Trimbos J, Dijkman A, Creutzberg CL, Gaarenstroom KN, et al. Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study. Int J Gynecol Cancer. 2006;16:1112\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"2808_CR26","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1002\/cam4.3645","volume":"10","author":"X Zhang","year":"2020","unstructured":"Zhang X, Bao B, Wang S, Yi M, Jiang L, Fang X. Sentinel lymph node biopsy in early-stage cervical cancer: a meta-analysis. Cancer Med. 2020;10(8):2590\u2013600.","journal-title":"Cancer Med"},{"key":"2808_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ygyno.2004.12.007","volume":"97","author":"LJ Havrilesky","year":"2005","unstructured":"Havrilesky LJ, Kulasingam SL, Matchar DB, et al. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol. 2005;97:183\u201391.","journal-title":"Gynecol Oncol"},{"issue":"17","key":"2808_CR28","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1200\/JCO.2001.19.17.3745","volume":"19","author":"PW Grigsby","year":"2001","unstructured":"Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol. 2001;19(17):3745\u20139. https:\/\/doi.org\/10.1200\/JCO.2001.19.17.3745 (PMID: 11533097).","journal-title":"J Clin Oncol"},{"issue":"12","key":"2808_CR29","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1200\/JCO.2009.25.4151","volume":"28","author":"EA Kidd","year":"2010","unstructured":"Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, Grigsby PW. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010;28(12):2108\u201313. https:\/\/doi.org\/10.1200\/JCO.2009.25.4151 (Epub 2010 Mar 22 PMID: 20308664).","journal-title":"J Clin Oncol"},{"issue":"2","key":"2808_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ijrobp.2009.02.020","volume":"76","author":"CS Tsai","year":"2010","unstructured":"Tsai CS, Lai CH, Chang TC, Yen TC, Ng KK, Hsueh S, Lee SP, Hong JH. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy. Int J Radiat Oncol Biol Phys. 2010;76(2):477\u201384. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.02.020 (Epub 2009 May 21 PMID: 19464824).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2808_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1053\/j.sult.2019.03.001","volume":"40","author":"C Devine","year":"2019","unstructured":"Devine C, Viswanathan C, Faria S, Marcal L, Sagebiel TL. Imaging and staging of cervical cancer. Semin Ultrasound CT MRI. 2019;40(4):280\u20136. https:\/\/doi.org\/10.1053\/j.sult.2019.03.001.","journal-title":"Semin Ultrasound CT MRI"},{"issue":"3","key":"2808_CR32","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3802\/jgo.2020.31.e54","volume":"31","author":"D Cibula","year":"2020","unstructured":"Cibula D. Management of patients with intermediate-risk early stage cervical c\u00e1ncer. J Gynecol Oncol. 2020;31(3):354.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"2808_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13014-018-1126-7.PMID:30217165;PMCID:PMC6137729","volume":"13","author":"Y Lin","year":"2018","unstructured":"Lin Y, Chen K, Lu Z, Zhao L, Tao Y, Ouyang Y, Cao X. Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis. Radiat Oncol. 2018;13(1):177. https:\/\/doi.org\/10.1186\/s13014-018-1126-7.PMID:30217165;PMCID:PMC6137729.","journal-title":"Radiat Oncol"},{"issue":"1","key":"2808_CR34","doi-asserted-by":"publisher","first-page":"CD012529","DOI":"10.1002\/14651858.CD012529.pub2","volume":"1","author":"TA Lawrie","year":"2018","unstructured":"Lawrie TA, Green JT, Beresford M, Wedlake L, Burden S, et al.\u00a0Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. Cochrane Database Syst Rev.\u00a02018;1(1):CD012529.\u00a0https:\/\/doi.org\/10.1002\/14651858.CD012529.pub2.","journal-title":"Cochrane Database Syst Rev."},{"key":"2808_CR35","unstructured":"Cibula D. An International Randomised Trial of Radical Surgery Followed by Adjuvant (Chemo)Radiation Versus no Further Treatment in Patients With Early-stage, Intermediate-risk\u00a0Cervical Cancer\u00a0Patients. (CERVANTES) https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04989647 (29 November 2021, last date accessed)."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02808-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-022-02808-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02808-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:52:43Z","timestamp":1700441563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-022-02808-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2808"],"URL":"https:\/\/doi.org\/10.1007\/s12094-022-02808-9","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent or the ethical committee contest was not necessary since this work includes a systematic review and meta-analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}